Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-2129 for Acute Gouty Arthritis
NCT07706777Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-2129 in acute gouty arthritis, sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Aug 2026; status: recruiting.
02
Drugs
HRS-2129
03
Conditions
acute gouty arthritis
Beyond the preview
Go deeper on NCT07706777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07706777.